Dupilumab-Related Ocular Disease: Unravelling the Link : vim

Ocular surface disease may be present at baseline in patients with AD treated with dupilumab.

Related Keywords

Montreal , Quebec , Canada , Netherlands , Utrecht , Melinda Gooderham , Roselie Achten , Vivian Shi , Sanofi Genzyme , Skin Centre For Dermatology , Atopic Dermatitis At University Medical Center Utrecht , National Expertise Center , Queens University , Peterborough Regional Health Centre , International Society Of Atopic Dermatitis , Department Of Dermatology , University Of Arkansas , International Society , Atopic Dermatitis , University Medical Center Utrecht , Eczema Area , Severity Index , Utrecht Ophthalmic Inflammatory , Medical Sciences , Medscape Medical , Medical Director , Presented October , Dermatitis , Adverse Effects , Side Effects , Allergic Conjunctivitis , Asthma , Sthmatic , Conjunctivitis , Corneal Disease , Eczema , Internship , Interns , Laceration , Ocular Allergies , Llergic Eye Diseases , Llergic Ophthalmologic Conditions , Patient Safety , Severity Indices , Wound Management ,